Alison D. Parisian - Concepedia

Author

Alison D. Parisian

University of California San Diego ORCID

Also Known As

Alison D Parisian, Alison D. Parisian, Alison Parisian

Publications

375

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Ludwig Cancer Research University of Minnesota Moores Cancer Center Rady Children's Hospital-San Diego

About

Alison D. Parisian is an author at University of California San Diego specializing in breast cancer, radiation oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	32
2	Endocrinology	1	1	32
3	Pharmacology	1	1	32
4	Drug Discovery	1	1	32
5	Aromatase	1	1	32

Alison D. Parisian

Publications

349

Citations

H-Index

Page 1

	Year	Citations
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity Ciro Zanca, Genaro R. Villa, Jorge A. Benítez, Genes & Development	2017	71
Oncogenic mutations at the EGFR ectodomain structurally converge to remove a steric hindrance on a kinase-coupled cryptic epitope Laura Orellana, Amy Haseley Thorne, Rafael Lema, Proceedings of the National Academy of Sciences	2019	55
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells Tomoyuki Koga, Isaac A. Chaim, Jorge A. Benítez, Nature Communications	2020	55
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability Alison D. Parisian, Tomoyuki Koga, Shunichiro Miki, Genes & Development	2020	45
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma Jorge A. Benítez, Darren Finlay, Anthony S. Castanza, Neuro-Oncology	2021	42
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination Alison D. Parisian, Susanna A. Barratt, Leslie Hodges-Gallagher, Molecular Cancer Therapeutics Breast OncologyChemoprevention StrategyMedicineHormonal ReceptorPharmacology	2023	32
Intron 1–Mediated Regulation of <i>EGFR</i> Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins Nathan M. Jameson, Jianhui Ma, Jorge A. Benítez, Molecular Cancer Research	2019	25
<i>TERT</i> promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening <i>in vivo</i> Shunichiro Miki, Tomoyuki Koga, Andrew McKinney, Neuro-Oncology	2022	14
EGFRvIII uses intrinsic and extrinsic mechanisms to reduce glioma adhesion and increase migration Afsheen Banisadr, Mariam Eick, Pranjali Beri, Journal of Cell Science	2020	10

Page 1